Matches in SemOpenAlex for { <https://semopenalex.org/work/W2546514134> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2546514134 endingPage "156" @default.
- W2546514134 startingPage "152" @default.
- W2546514134 abstract "Aim. Assessment of infections prevalence rate, type and severity in patients diagnosed with progressive systemic sclerosis (PSS), treated with cyclophosphamide (CTX), during 12 months of observations. Material and methods. A retrospective analysis of mild, moderate and severe infections in 17 women with a mean age of 58.8 ± 10.0, based on an interview, physical examination, additional tests, and available medical records. Results. 46 various infections were diagnosed in the analysed group of patients. 32 (69.6%) infections involved the respiratory system, and 14 (30.4%) infections concerned the urinary tract. The average frequency per one patient was 2.7 ± 3.5 (median: 2) events during 12 months of observations. The majority of infections, 60.9 % (n = 28), were mild ones of slight intensity, and 37.0% (n = 17) were moderate ones. Only one person (2.2% of all infections) had a severe infection requiring hospitalisation.Conclusions. In the studied group the infection prevalence rate was comparable to that in a healthy population. The majority of infections were mild and involved the respiratory system. Basis of conducted analysis 12 months intravenous administration of CTX is not a factor significantly increasing a risk of severe infections in the studied group of patients. In PSS patients CTX pulse therapy is relatively safe, as it does not cause severe infections requiring hospitalisation" @default.
- W2546514134 created "2016-11-11" @default.
- W2546514134 creator A5036435947 @default.
- W2546514134 creator A5041653844 @default.
- W2546514134 creator A5044038068 @default.
- W2546514134 date "2015-09-30" @default.
- W2546514134 modified "2023-09-23" @default.
- W2546514134 title "Retrospective analysis of infections prevalence in patients with progressive systemic sclerosis treated with cyclophosphamide" @default.
- W2546514134 cites W113068169 @default.
- W2546514134 cites W1554549676 @default.
- W2546514134 cites W1851470352 @default.
- W2546514134 cites W2016812439 @default.
- W2546514134 cites W2026143574 @default.
- W2546514134 cites W2029779365 @default.
- W2546514134 cites W2037288299 @default.
- W2546514134 cites W2056364917 @default.
- W2546514134 cites W2066165267 @default.
- W2546514134 cites W2086003187 @default.
- W2546514134 cites W2091867969 @default.
- W2546514134 cites W2127353573 @default.
- W2546514134 cites W2131014787 @default.
- W2546514134 cites W2138183967 @default.
- W2546514134 cites W2155039875 @default.
- W2546514134 cites W2413009377 @default.
- W2546514134 cites W2508060872 @default.
- W2546514134 doi "https://doi.org/10.20883/medical.e12" @default.
- W2546514134 hasPublicationYear "2015" @default.
- W2546514134 type Work @default.
- W2546514134 sameAs 2546514134 @default.
- W2546514134 citedByCount "0" @default.
- W2546514134 crossrefType "journal-article" @default.
- W2546514134 hasAuthorship W2546514134A5036435947 @default.
- W2546514134 hasAuthorship W2546514134A5041653844 @default.
- W2546514134 hasAuthorship W2546514134A5044038068 @default.
- W2546514134 hasBestOaLocation W25465141341 @default.
- W2546514134 hasConcept C126322002 @default.
- W2546514134 hasConcept C141071460 @default.
- W2546514134 hasConcept C167135981 @default.
- W2546514134 hasConcept C195910791 @default.
- W2546514134 hasConcept C2776012195 @default.
- W2546514134 hasConcept C2776694085 @default.
- W2546514134 hasConcept C2776755627 @default.
- W2546514134 hasConcept C2908647359 @default.
- W2546514134 hasConcept C534529494 @default.
- W2546514134 hasConcept C71924100 @default.
- W2546514134 hasConcept C77411442 @default.
- W2546514134 hasConcept C99454951 @default.
- W2546514134 hasConceptScore W2546514134C126322002 @default.
- W2546514134 hasConceptScore W2546514134C141071460 @default.
- W2546514134 hasConceptScore W2546514134C167135981 @default.
- W2546514134 hasConceptScore W2546514134C195910791 @default.
- W2546514134 hasConceptScore W2546514134C2776012195 @default.
- W2546514134 hasConceptScore W2546514134C2776694085 @default.
- W2546514134 hasConceptScore W2546514134C2776755627 @default.
- W2546514134 hasConceptScore W2546514134C2908647359 @default.
- W2546514134 hasConceptScore W2546514134C534529494 @default.
- W2546514134 hasConceptScore W2546514134C71924100 @default.
- W2546514134 hasConceptScore W2546514134C77411442 @default.
- W2546514134 hasConceptScore W2546514134C99454951 @default.
- W2546514134 hasIssue "3" @default.
- W2546514134 hasLocation W25465141341 @default.
- W2546514134 hasOpenAccess W2546514134 @default.
- W2546514134 hasPrimaryLocation W25465141341 @default.
- W2546514134 hasRelatedWork W2002120878 @default.
- W2546514134 hasRelatedWork W2003938723 @default.
- W2546514134 hasRelatedWork W2047967234 @default.
- W2546514134 hasRelatedWork W2118496982 @default.
- W2546514134 hasRelatedWork W2269754317 @default.
- W2546514134 hasRelatedWork W2419921872 @default.
- W2546514134 hasRelatedWork W2439875401 @default.
- W2546514134 hasRelatedWork W2746546611 @default.
- W2546514134 hasRelatedWork W4238867864 @default.
- W2546514134 hasRelatedWork W2525756941 @default.
- W2546514134 hasVolume "84" @default.
- W2546514134 isParatext "false" @default.
- W2546514134 isRetracted "false" @default.
- W2546514134 magId "2546514134" @default.
- W2546514134 workType "article" @default.